Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions

Archives of Toxicology

Volumn 81, Issue 5, 2007, Pages 335-346

  Bader, Michael ^a   Wrbitzky, Renate ^a   Blaszkewicz, Meinolf ^b   Van Thriel, Christoph ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Biomonitoring; Experimental exposure; N Methyl 2 pyrrolidone

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2 HYDROXY N METHYLSUCCINIMIDE; 2 PYRROLIDONE DERIVATIVE; 5 HYDROXY N METHYL 2 PYRROLIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BICYCLE ERGOMETER; BIOLOGICAL MONITORING; CREATININE URINE LEVEL; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TOXICOKINETICS; URINALYSIS; VOLUNTEER; WORKPLACE;

ADMINISTRATION, INHALATION; ADULT; AIR POLLUTANTS, OCCUPATIONAL; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE TEST; HALF-LIFE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MOLECULAR STRUCTURE; OCCUPATIONAL EXPOSURE; PYRROLIDINONES; REST; STATISTICS; SUCCINIMIDES; TERATOGENS; TIME FACTORS; TOXICOLOGY; WORKLOAD; WORKPLACE;

EID: 34247854902     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-006-0161-6     Document Type: Article

References (23)

1. Åkesson B (2001) N-Methyl-2-pyrrolidone. Concise international chemical assessment document 35, International programme on chemical safety, World Health Organization, Geneva
2. Åkesson B, Carnerup M, Jönsson BAG (2004) Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2- pyrrolidone. Scand J Work Environ Health 30:306-312
3. Åkesson B, Jönsson BAG (1997) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 25:267-269
4. Åkesson B, Jönsson BAG (2000) Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker. Scand J Work Environ Health 26:213-218
5. Åkesson B, Paulsson K (1997) Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54:236-240
6. Akrill P, Cocker J, Dixon S (2002) Dermal exposure to aqueous solutions of N-methylpyrrolidone. Toxicol Lett 134:265-269
7. Anundi H, Langworth S, Johanson G, Lind ML, Åkesson B, Friis L, Itkes N, Söderman E, Jönsson BAG, Edling C (2000) Air and biological monitoring of solvent exposure during graffiti removal. Int Arch Occup Environ Health 73:561-569
8. Anundi H, Lind ML, Friis L, Itkes N, Langworth S, Edling C (1993) High exposures to organic solvents among graffiti removers. Int Arch Occup Environ Health 65:247-251
9. Bader M, Keener SA, Wrbitzky R (2005) Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone. Int Arch Occup Environ Health 78:673-676
10. Bader M, Rosenberger W, Rebe Th, Keener S, Brock TH, Hemmerling H, Wrbitzky R (2006) Ambient monitoring and biomonitoring of workers exposed to N-methyl-2-pyrrolidone (NMP) in an industrial facility. Int Arch Occup Environ Health 79:357-364
11. Bader M, Will W, Rossbacher R, Nasterlack M, Wrbitzky R (2002) N-Methyl-2-pyrrolidon - Arbeitsmedizinische Bedeutung und Toxikologie. Arbeitsmed Sozialmed Umweltmed 9:422-428
12. Beaulieu HJ, Schmerber KR (1991) M-Pyrol(™) (NMP) use in the microelectronics industry. Appl Occup Environ Hyg 6:874-880
13. Carnerup MA (2004) Analysis, metabolism, effects and biological monitoring of N-methyl-2-pyrrolidone (NMP). Thesis, Faculty of Medicine, Lund University, Sweden
14. Carnerup MA, Spanne M, Jönsson BA (2006) Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air. Toxicol Lett 162:139-45
15. DFG (Deutsche Forschungsgemeinschaft) (2006) List of MAK and BAT values 2006. Report No. 42, Wiley-VCH, Weinheim
16. Greim H (ed.) (2006) N-Methyl-2-pyrrolidon (Dampf). Maximale Arbeitsplatzkonzentrationen. Arbeitsmedizinischtoxikologische Begründungen. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Deutsche Forschungsgemeinschaft. 41. Lieferung, Wiley-VCH, Weinheim
17. Greim H, Lehnert G (eds.) (1998) Die Bedeutung der Arbeitsleistung für die Inhalationskinetik. Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten, Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Deutsche Forschungsgemeinschaft. 27. Lieferung, Wiley-VCH, Weinheim
18. HSE (Health and Safety Executive) (1997) N-Methyl-2-pyrrolidone. Risk assessment document. EH72/10, ISBN 0717615286, HSE Books, Sudbury, UK
19. Jönsson BAG, Åkesson B (1997) Determination of 5-hydroxy-Nmethylpyrrolidone and 2-hydroxy-N-methylsuccinimide in human urine. J Chrom B 694:351-357
20. Jönsson BAG, Åkesson B (2003) Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy-N- methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy-N- methylsuccinimide (2-HMSI) and biological monitoring using 2-HMSI as a biomarker. Int Arch Occup Environ Health 76:267-274
21. Langworth S, Anundi H, Friis L, Johanson G, Lind ML, Söderman E, Åkesson B (2001) Acute health effects common during graffiti removal. Int Arch Occup Environ Health 74:213-218
22. Ligocka D, Lison D, Haufroid V (2003) Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism. Arch Toxicol 77:261-266
23. 14C]pyrrolidinone in the rat. Food Chem Toxic 30:57-64